Swift and strong NK cell responses protect 129 mice against high-dose influenza virus infection

Journal of Immunology

Volumn 196, Issue 4, 2016, Pages 1842-1854

  Zhou, Kai ^a   Wang, Jing ^a,b   Li, An ^a,c   Zhao, Wenming ^a   Wang, Dongfang ^a,b   Zhang, Wei ^a   Yan, Jinghua ^a   Gao, George Fu ^a   Liu, Wenjun ^a   Fang, Min ^a  

^a INSTITUTE OF MICROBIOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c GUANGXI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL1 CHEMOKINE; CXCL9 CHEMOKINE; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERFERON; INTERLEUKIN 12; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 5; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; RETINOIC ACID INDUCIBLE PROTEIN I; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; INFLAMMATION; INFLUENZA A (H1N1); MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SURVIVAL; VIRUS REPLICATION; VIRUS TITRATION; 129 MOUSE; ANIMAL; BIOSYNTHESIS; DISEASE MODEL; FLOW CYTOMETRY; GENETICS; IMMUNOLOGY; INFLUENZA A VIRUS (H1N1); LYMPHOCYTE ACTIVATION; ORTHOMYXOVIRUS INFECTION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CYTOKINES; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; INFLUENZA A VIRUS, H1N1 SUBTYPE; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MICE; MICE, 129 STRAIN; ORTHOMYXOVIRIDAE INFECTIONS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84958580531     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1501486     Document Type: Article

References (49)

1. Matrosovich, M. N., T. Y. Matrosovich, T. Gray, N. A. Roberts, and H. D. Klenk. 2004. Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proc. Natl. Acad. Sci. USA 101: 4620-4624.
2. Langlois, R. A., A. Varble, M. A. Chua, A. García-Sastre, and B. R. tenOever. 2012. Hematopoietic-specific targeting of influenza A virus reveals replication requirements for induction of antiviral immune responses. Proc. Natl. Acad. Sci. USA 109: 12117-12122.
3. Manicassamy, B., S. Manicassamy, A. Belicha-Villanueva, G. Pisanelli, B. Pulendran, and A. García-Sastre. 2010. Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus. Proc. Natl. Acad. Sci. USA 107: 11531-11536.
4. Smed-Sörensen, A., C. Chalouni, B. Chatterjee, L. Cohn, P. Blattmann, N. Nakamura, L. Delamarre, and I. Mellman. 2012. Influenza A virus infection of human primary dendritic cells impairs their ability to cross-present antigen to CD8 T cells. PLoS Pathog. 8: e1002572.
5. Sanders, C. J., P. C. Doherty, and P. G. Thomas. 2011. Respiratory epithelial cells in innate immunity to influenza virus infection. Cell Tissue Res. 343: 13-21.
6. Yatim, N., and M. L. Albert. 2011. Dying to replicate: The orchestration of the viral life cycle, cell death pathways, and immunity. Immunity 35: 478-490.
7. Takeuchi, O., and S. Akira. 2009. Innate immunity to virus infection. Immunol. Rev. 227: 75-86.
8. Julkunen, I., T. Sareneva, J. Pirhonen, T. Ronni, K. Melén, and S. Matikainen. 2001. Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene expression. Cytokine Growth Factor Rev. 12: 171-180.
9. French, A. R., and W. M. Yokoyama. 2003. Natural killer cells and viral infections. Curr. Opin. Immunol. 15: 45-51.
10. Wu, J., and L. L. Lanier. 2003. Natural killer cells and cancer. Adv. Cancer Res. 90: 127-156.
11. Biron, C. A., K. S. Byron, and J. L. Sullivan. 1989. Severe herpesvirus infections in an adolescent without natural killer cells. N. Engl. J. Med. 320: 1731-1735.
12. Etzioni, A., C. Eidenschenk, R. Katz, R. Beck, J. L. Casanova, and S. Pollack. 2005. Fatal varicella associated with selective natural killer cell deficiency. J. Pediatr. 146: 423-425.
13. + T cells. Nat. Rev. Immunol. 11: 645-657.
14. Orange, J. S. 2002. Human natural killer cell deficiencies and susceptibility to infection. Microbes Infect. 4: 1545-1558.
15. Bukowski, J. F., B. A. Woda, and R. M. Welsh. 1984. Pathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice. J. Virol. 52: 119-128.
16. Lanier, L. L. 2008. Evolutionary struggles between NK cells and viruses. Nat. Rev. Immunol. 8: 259-268.
17. Brizić, I., T. Lenac Rovis, A. Krmpotić, and S. Jonjić. 2014. MCMV avoidance of recognition and control by NK cells. Semin. Immunopathol. 36: 641-650.
18. Fang, M., L. L. Lanier, and L. J. Sigal. 2008. A role for NKG2D in NK cellmediated resistance to poxvirus disease. PLoS Pathog. 4: e30.
19. Delano, M. L., and D. G. Brownstein. 1995. Innate resistance to lethal mousepox is genetically linked to the NK gene complex on chromosome 6 and correlates with early restriction of virus replication by cells with an NK phenotype. J. Virol. 69: 5875-5877.
20. Fang, M., M. T. Orr, P. Spee, T. Egebjerg, L. L. Lanier, and L. J. Sigal. 2011. CD94 is essential for NK cell-mediated resistance to a lethal viral disease. Immunity 34: 579-589.
21. Gazit, R., R. Gruda, M. Elboim, T. I. Arnon, G. Katz, H. Achdout, J. Hanna, U. Qimron, G. Landau, E. Greenbaum, et al. 2006. Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat. Immunol. 7: 517-523.
22. Nogusa, S., B. W. Ritz, S. H. Kassim, S. R. Jennings, and E. M. Gardner. 2008. Characterization of age-related changes in natural killer cells during primary influenza infection in mice. Mech. Ageing Dev. 129: 223-230.
23. Stein-Streilein, J., and J. Guffee. 1986. In vivo treatment of mice and hamsters with antibodies to asialo GM1 increases morbidity and mortality to pulmonary influenza infection. J. Immunol. 136: 1435-1441.
24. Zhou, G., S. W. Juang, and K. P. Kane. 2013. NK cells exacerbate the pathology of influenza virus infection in mice. Eur. J. Immunol. 43: 929-938.
25. Abdul-Careem, M. F., M. F. Mian, G. Yue, A. Gillgrass, M. J. Chenoweth, N. G. Barra, M. V. Chew, T. Chan, A. A. Al-Garawi, M. Jordana, and A. A. Ashkar. 2012. Critical role of natural killer cells in lung immunopathology during influenza infection in mice. J. Infect. Dis. 206: 167-177.
26. Kumar, P., M. S. Thakar, W. Ouyang, and S. Malarkannan. 2013. IL-22 from conventional NK cells is epithelial regenerative and inflammation protective during influenza infection. Mucosal Immunol. 6: 69-82.
27. Paget, C., S. Ivanov, J. Fontaine, J. Renneson, F. Blanc, M. Pichavant, L. Dumoutier, B. Ryffel, J. C. Renauld, P. Gosset, et al. 2012. Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epithelial damages. J. Biol. Chem. 287: 8816-8829.
28. Ge, M. Q., A. W. Ho, Y. Tang, K. H. Wong, B. Y. Chua, S. Gasser, and D. M. Kemeny. 2012. NK cells regulate CD8+ T cell priming and dendritic cell migration during influenza A infection by IFN-g and perforin-dependent mechanisms. J. Immunol. 189: 2099-2109.
29. Srivastava, B., P. Błazejewska, M. Hessmann, D. Bruder, R. Geffers, S. Mauel, A. D. Gruber, and K. Schughart. 2009. Host genetic background strongly influences the response to influenza a virus infections. PLoS One 4: e4857.
30. Davidson, S., S. Crotta, T. M. McCabe, and A. Wack. 2014. Pathogenic potential of interferon ab in acute influenza infection. Nat. Commun. 5: 3864.
31. Fang, M., F. Roscoe, and L. J. Sigal. 2010. Age-dependent susceptibility to a viral disease due to decreased natural killer cell numbers and trafficking. J. Exp. Med. 207: 2369-2381.
32. Zhang, W., Y. Shi, J. Qi, F. Gao, Q. Li, Z. Fan, J. Yan, and G. F. Gao. 2013. Molecular basis of the receptor binding specificity switch of the hemagglutinins from both the 1918 and 2009 pandemic influenza A viruses by a D225G substitution. J. Virol. 87: 5949-5958.
33. Dons'koi, B. V., V. P. Chernyshov, and D. V. Osypchuk. 2011. Measurement of NK activity in whole blood by the CD69 up-regulation after co-incubation with K562, comparison with NK cytotoxicity assays and CD107a degranulation assay. J. Immunol. Methods 372: 187-195.
34. Schultz-Cherry, S. 2015. Role of NK cells in influenza infection. Curr. Top. Microbiol. Immunol. 386: 109-120.
35. van Helden, M. J., D. M. Zaiss, and A. J. Sijts. 2012. CCR2 defines a distinct population of NK cells and mediates their migration during influenza virus infection in mice. PLoS One 7: e52027.
36. Biron, C. A., K. B. Nguyen, and G. C. Pien. 2002. Innate immune responses to LCMV infections: natural killer cells and cytokines. Curr. Top. Microbiol. Immunol. 263: 7-27.
37. Mandelboim, O., N. Lieberman, M. Lev, L. Paul, T. I. Arnon, Y. Bushkin, D. M. Davis, J. L. Strominger, J. W. Yewdell, and A. Porgador. 2001. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 409: 1055-1060.
38. Le Goffic, R., J. Pothlichet, D. Vitour, T. Fujita, E. Meurs, M. Chignard, and M. Si-Tahar. 2007. Cutting edge: influenza A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells. J. Immunol. 178: 3368-3372.
39. Ichinohe, T. 2010. Respective roles of TLR, RIG-I and NLRP3 in influenza virus infection and immunity: impact on vaccine design. Expert Rev. Vaccines 9: 1315-1324.
40. Fitzgerald, K. A., S. M. McWhirter, K. L. Faia, D. C. Rowe, E. Latz, D. T. Golenbock, A. J. Coyle, S. M. Liao, and T. Maniatis. 2003. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4: 491-496.
41. Sharma, S., B. R. tenOever, N. Grandvaux, G. P. Zhou, R. Lin, and J. Hiscott. 2003. Triggering the interferon antiviral response through an IKK-related pathway. Science 300: 1148-1151.
42. Horby, P., N. Y. Nguyen, S. J. Dunstan, and J. K. Baillie. 2013. An updated systematic review of the role of host genetics in susceptibility to influenza. Influenza Other Respi. Viruses 7(Suppl. 2): 37-41.
43. Horby, P., N. Y. Nguyen, S. J. Dunstan, and J. K. Baillie. 2012. The role of host genetics in susceptibility to influenza: A systematic review. PLoS One 7: e33180.
44. Karlas, A., N. Machuy, Y. Shin, K. P. Pleissner, A. Artarini, D. Heuer, D. Becker, H. Khalil, L. A. Ogilvie, S. Hess, et al. 2010. Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. Nature 463: 818-822.
45. Boon, A. C., J. deBeauchamp, A. Hollmann, J. Luke, M. Kotb, S. Rowe, D. Finkelstein, G. Neale, L. Lu, R. W. Williams, and R. J. Webby. 2009. Host genetic variation affects resistance to infection with a highly pathogenic H5N1 influenza A virus in mice. J. Virol. 83: 10417-10426.
46. Waggoner, S. N., M. Cornberg, L. K. Selin, and R. M. Welsh. 2012. Natural killer cells act as rheostats modulating antiviral T cells. Nature 481: 394-398.
47. Lodoen, M. B., and L. L. Lanier. 2005. Viral modulation of NK cell immunity. Nat. Rev. Microbiol. 3: 59-69.
48. Sadler, A. J., and B. R. Williams. 2008. Interferon-inducible antiviral effectors. Nat. Rev. Immunol. 8: 559-568.
49. Nguyen, K. B., T. P. Salazar-Mather, M. Y. Dalod, J. B. Van Deusen, X. Q. Wei, F. Y. Liew, M. A. Caligiuri, J. E. Durbin, and C. A. Biron. 2002. Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection. J. Immunol. 169: 4279-4287.